Clinical Trials Directory

Trials / Sponsors / miRagen Therapeutics, Inc.

miRagen Therapeutics, Inc.

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
TerminatedPRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the S
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Phase 22019-10-01
TerminatedSOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Phase 22019-04-02
CompletedEfficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a H
Keloid
Phase 22018-06-11
CompletedSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MRG-110 Following Intradermal Injection in Hea
Healthy Volunteer
Phase 12018-04-09
CompletedSafety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or AT
Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides (MF), Chronic Lymphocytic Leukemia (CLL)
Phase 12016-02-09
CompletedSafety, Tolerability and Pharmacokinetic Study of MRG-201 in Healthy Volunteers
Healthy Volunteers
Phase 12015-11-01